GlassScriptPhysician profile
Shamil Surendra Patel
NPI 1821298134
$116,222.81
in general payments reported to CMS, 2019-2025
30 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,690 · 2020: $3,556 · 2021: $12K · 2022: $33K · 2023: $13K · 2024: $18K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,750 · Food and Beverage: $9,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,925.00 |
| Travel and Lodging | $13,288.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,750.00 |
| Food and Beverage | $9,227.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nova Eye, INC. | $74,502.43 | 2021-2025 | |
| Glaukos Corporation | $28,632.22 | 2019-2025 | Idose, Travoprost Intraocular Implant - Idose, Idosetr |
| Aerie Pharmaceuticals, INC. | $3,189.29 | 2019-2021 | |
| Alcon Vision LLC | $1,872.09 | 2020-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Abbvie INC. | $1,565.62 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $1,514.77 | 2022-2025 | Vyzulta, Miebo, Envista Aspire Toric Iol |
| Allergan, INC. | $1,191.74 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $600.00 | 2023 | Artevo 800 |
| New World Medical,INC. | $541.03 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Rxsight INC | $422.49 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Novartis Pharmaceuticals Corporation | $373.82 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $365.08 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $225.71 | 2020-2025 | Cequa, Xelpros, Bromsite |
| Eyevance Pharmaceuticals LLC | $170.73 | 2019 | |
| Ivantis, INC | $160.24 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $150.03 | 2021-2025 | Tecnis Iol, Tecnis Simplicity |
| Ocular Therapeutix, INC. | $150.00 | 2024 | |
| Genentech USA, INC. | $81.04 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $73.65 | 2023 | Clarus |
| Heidelberg Engineering, INC. | $67.73 | 2023 | Spectralis |
| Sight Sciences, INC. | $67.47 | 2022 | |
| Kala Pharmaceuticals, INC. | $64.58 | 2019-2020 | |
| Rayner Intraocular Lenses Limited | $62.61 | 2024-2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
| Tearlab Corp | $39.73 | 2023 | Tearlab Osmolarity System |
| Thea Pharma INC. | $33.51 | 2023-2024 | Iyuzeh |
| Astellas Pharma US INC | $29.70 | 2024 | Izervay |
| W. L. Gore & Associates, INC. | $24.75 | 2025 | Product In Development |
| Amgen INC. | $21.46 | 2025 | Tepezza |
| Akorn, INC. | $15.28 | 2020 | |
| Akorn Operating Company LLC | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shamil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.